1 | A4250 | - | - | - | - | 4件: 93 93, 296, 297, 338 |
2 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
3 | Ammonia | 1件: Ammonia Ammonia | 1件: D02916
D02916
| - | - | 2件: 6 6, 296 |
4 | BELIMUMAB | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
5 | Bezafibrate | 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
6 | Bicarbonate Ringer's solution | - | - | - | - | 1件: 296 296 |
7 | Cefoperazone | 1件: Cefoperazone Cefoperazone | 1件: D07645
D07645
| - | - | 1件: 296 296 |
8 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
9 | Combination Product: high MCT formula | - | - | - | - | 1件: 296 296 |
10 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 |
11 | Cysteine | 1件: Cysteine Cysteine | - | - | - | 10件: 13 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 |
12 | Desflurane | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 2件: 22 22, 296 |
13 | Desflurane anesthetics | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 1件: 296 296 |
14 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
15 | DIMETHYL FUMARATE | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 4件: 13 13, 51, 86, 296 |
16 | Eicosapentaenoic acid | 1件: Icosapent Icosapent | 1件: D08061
D08061
| - | - | 6件: 49 49, 96, 97, 296, 297, 338 |
17 | Epadel | - | - | - | - | 1件: 296 296 |
18 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 28件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
19 | Folic acid | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 5件: 6 6, 46, 49, 84, 296 |
20 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 |
21 | Granulocyte Colony-Stimulating Factor | - | - | - | - | 1件: 296 296 |
22 | ICG Pulsion | - | - | - | - | 1件: 296 296 |
23 | ICG-Pulsion 25mg | - | - | - | - | 1件: 296 296 |
24 | Indocyanine green | 1件: Indocyanine green Indocyanine green | 1件: D01342
D01342
| - | - | 8件: 22 22, 46, 51, 96, 235, 278, 291, 296 |
25 | Intravenous immunoglobulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 14 14, 17, 164, 296 |
26 | Lactated Ringer | - | - | - | - | 1件: 296 296 |
27 | Lactobacillus casei | 1件: Lactobacillus casei Lactobacillus casei | 1件: D04351
D04351
| - | - | 3件: 6 6, 97, 296 |
28 | Lactobacillus casei rhamnosus (Lcr35) | 1件: Lactobacillus casei Lactobacillus casei | 1件: D04351
D04351
| - | - | 1件: 296 296 |
29 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 15件: 6 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 |
30 | Magnesium gluconate | 2件: Magnesium Magnesium, Magnesium gluconate | 1件: D04835
D04835
| - | - | 2件: 296 296, 297 |
31 | Magnesium sulfate | 3件: Magnesium gluconate Magnesium gluconate, Magnesium sulfate, Sulfate ion | 2件: D01108
D01108
,
D04835
| - | - | 3件: 11 11, 296, 297 |
32 | Maralixibat | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
33 | Maralixibat (formely SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
34 | MARALIXIBAT CHLORIDE | 2件: Chloride ion Chloride ion, Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
35 | Maralixibat cloruro | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 2件: 296 296, 338 |
36 | MCT | - | - | - | - | 2件: 6 6, 296 |
37 | MCT powder | - | - | - | - | 1件: 296 296 |
38 | Meloxicam | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 46 46, 49, 271, 296 |
39 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
40 | N-acetyl cysteine | 1件: Cysteine Cysteine | - | - | - | 6件: 13 13, 34, 85, 88, 296, 310 |
41 | Neomycin | 1件: Neomycin Neomycin | 1件: D08260
D08260
| - | - | 3件: 96 96, 97, 296 |
42 | Norepinephrine | 1件: Norepinephrine Norepinephrine | 1件: D00076
D00076
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 22 22, 296 |
43 | Norepinephrine Bitartrate | 1件: Norepinephrine Norepinephrine | 1件: D00076
D00076
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 296 296 |
44 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
45 | Obeticholic Acid | 1件: Obeticholic acid Obeticholic acid | 1件: D09360
D09360
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 93 93, 265, 296 |
46 | OCA | - | - | - | - | 2件: 94 94, 296 |
47 | OCA 0.1 mg | - | - | - | - | 1件: 296 296 |
48 | OCA 0.1mg | - | - | - | - | 1件: 296 296 |
49 | OCA 1.5mg | - | - | - | - | 1件: 296 296 |
50 | OCA 5mg | - | - | - | - | 1件: 296 296 |
51 | Ocaliva | 1件: Obeticholic acid Obeticholic acid | 1件: D09360
D09360
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 2件: 93 93, 296 |
52 | Odevixibat | 1件: Odevixibat Odevixibat | 1件: D11716
D11716
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 296 296, 297, 338 |
53 | Oral Vancomycin | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 2件: 94 94, 296 |
54 | Other Crystalloid | - | - | - | - | 1件: 296 296 |
55 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: D00501
D00501
| - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 |
56 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
57 | Propanolol | 1件: Propranolol Propranolol | 1件: D08443
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 296 296 |
58 | PROPOFOL | 1件: Propofol Propofol | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 8件: 6 6, 21, 22, 34, 46, 70, 98, 296 |
59 | Rifaximin | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 8件: 6 6, 65, 93, 96, 97, 99, 296, 299 |
60 | RITUXIMAB | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
61 | Rocuronium | 1件: Rocuronium Rocuronium | - | - | - | 2件: 70 70, 296 |
62 | Sevoflurane | 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
63 | Sevoflurane anesthetics | 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 1件: 296 296 |
64 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
65 | UDCA | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 6件: 46 46, 67, 93, 94, 97, 296 |
66 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | - | - | - | - | 2件: 93 93, 296 |
67 | Ursodeoxycholic acid | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 10件: 6 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 |
68 | Vancomycin | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 |
69 | VO4CX | - | - | - | - | 1件: 296 296 |